Literature DB >> 19760674

No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample.

Sarah E Bergen1,2, Ayman H Fanous1,3,4,5, Po-Hsiu Kuo6, Brandon K Wormley1,3, F Anthony O'Neill7, Dermot Walsh8, Brien P Riley1,2,3, Kenneth S Kendler1,2,3.   

Abstract

Robust associations between the dysbindin gene (DTNBP1) and schizophrenia have been demonstrated in many but not all samples, and evidence that this gene particularly predisposes to negative symptoms in this illness has been presented. The current study sought to replicate the previously reported negative symptom associations in an Irish case-control sample. Association between dysbindin and schizophrenia has been established in this cohort, and a factor analysis of the assessed symptoms yielded three factors, Positive, Negative, and Schneiderian. The sequential addition method was applied using UNPHASED to assess the relationship between these symptom factors and the high-risk haplotype. No associations were detected for any of the symptom factors indicating that the dysbindin risk haplotype does not predispose to a particular group of symptoms in this sample. Several possibilities, such as differing risk haplotypes, may explain this finding. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19760674      PMCID: PMC2859300          DOI: 10.1002/ajmg.b.31029

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  47 in total

1.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

2.  Candidate genes for schizophrenia: a survey of association studies and gene ranking.

Authors:  Jingchun Sun; Po-Hsiu Kuo; Brien P Riley; Kenneth S Kendler; Zhongming Zhao
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

3.  Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.

Authors:  M A Benson; S E Newey; E Martin-Rendon; R Hawkes; D J Blake
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

4.  Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples.

Authors:  Elizabeth G Holliday; Herlina Y Handoko; Michael R James; John J McGrath; Deborah A Nertney; Sujit Tirupati; Rangaswamy Thara; Douglas F Levinson; Nicholas K Hayward; Bryan J Mowry; Dale R Nyholt
Journal:  Twin Res Hum Genet       Date:  2006-08       Impact factor: 1.587

5.  Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations.

Authors:  T Li; F Zhang; X Liu; X Sun; P C Sham; C Crombie; X Ma; Q Wang; H Meng; W Deng; P Yates; X Hu; N Walker; R M Murray; D St Clair; D A Collier
Journal:  Mol Psychiatry       Date:  2005-11       Impact factor: 15.992

6.  Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.

Authors:  Mousumi Mutsuddi; Derek W Morris; Skye G Waggoner; Mark J Daly; Edward M Scolnick; Pamela Sklar
Journal:  Am J Hum Genet       Date:  2006-10-03       Impact factor: 11.025

7.  The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population.

Authors:  Eun-Jeong Joo; Kyu-Young Lee; Seong Hoon Jeong; Yong-Min Ahn; Young Jin Koo; Yong Sik Kim
Journal:  Neurosci Lett       Date:  2006-09-07       Impact factor: 3.046

8.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.

Authors:  Brien Riley; Po-Hsiu Kuo; Brion S Maher; Ayman H Fanous; Jingchun Sun; Brandon Wormley; F Anthony O'Neill; Dermot Walsh; Zhongming Zhao; Kenneth S Kendler
Journal:  Schizophr Res       Date:  2009-10-02       Impact factor: 4.939

10.  Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.

Authors:  E J C G van den Oord; P F Sullivan; Y Jiang; D Walsh; F A O'Neill; K S Kendler; B P Riley
Journal:  Mol Psychiatry       Date:  2003-05       Impact factor: 15.992

View more
  3 in total

1.  Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes.

Authors:  Alexis C Edwards; Tim B Bigdeli; Anna R Docherty; Silviu Bacanu; Donghyung Lee; Teresa R de Candia; Arden Moscati; Dawn L Thiselton; Brion S Maher; Brandon K Wormley; Dermot Walsh; Francis A O'Neill; Kenneth S Kendler; Brien P Riley; Ayman H Fanous
Journal:  Schizophr Bull       Date:  2015-08-27       Impact factor: 9.306

2.  Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD.

Authors:  Anil K Malhotra
Journal:  Schizophr Bull       Date:  2013-10-10       Impact factor: 9.306

3.  Hodological resonance, hodological variance, psychosis, and schizophrenia: a hypothetical model.

Authors:  Paul Brian Lawrie Birkett
Journal:  Front Psychiatry       Date:  2011-07-25       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.